Gilead Sciences to Present at Two Upcoming Investor Conferences

- Morgan Stanley Global Healthcare Conference on September 14th -
- Bank of America Merrill Lynch Global Healthcare Conference 2010 on September 15th -
- Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif., Sep 08, 2010 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will be webcasting its corporate presentation at two upcoming investor conferences: the Morgan Stanley Global Healthcare Conference in New York and the Bank of America Merrill Lynch Global Healthcare Conference in London.

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at the Morgan Stanley conference on Tuesday, September 14 at 1:35 p.m. Eastern Daylight Time (EDT).

Kevin Young, Gilead's Executive Vice President, Commercial Operations, will provide an overview of the company at the Bank of America Merrill Lynch conference on Wednesday, September 15 at 1:45 p.m. British Summer Time (8:45 a.m. EDT).

To access the live webcasts via the internet log on to http://www.gilead.com. Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
Investor Relations